[1] DELGADO G E, KLEBER M E, MOISSL A P, et al. Surrogate scores of advanced fibrosis inNAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk[J]. Am J Physiol Gastrointest Liver Physiol, 2021, 321(3): G252-G261. [2] 屠燕, 杨婵娟, 黄莹, 等. 非酒精性脂肪肝与心血管疾病相关性的研究[J]. 自然杂志, 2022, 44(2): 149-154. [3] BÄCK M, YURDAGUL A Jr, TABAS I, et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities[J]. Nat Rev Cardiol, 2019, 16(7): 389-406. [4] 李毅, 韩雅玲. 2023 ESC急性冠脉综合征管理指南解读[J]. 中华心血管病杂志, 2023, 51(12): 1263-1267. [5] ROSTAMI R, NAJAFI M, SARAMI R, et al. Gensini scores and well-being states among patients with coronary artery disease: a comparison study[J]. ARYA Atheroscler, 2017, 13(5): 205-210. [6] CAZACG D, LÄCÄTUS,U C M, MIHAI C, et al. New insights into non-alcoholic fatty liver disease and coronary artery disease: the liver-heart axis[J]. Life, 2022, 12(8): 1189. [7] 宋璟景. 肝脏代谢紊乱对冠心病的预后价值及其潜在治疗靶点的研究[D]. 北京: 北京协和医学院, 2023. [8] CHEN Q, LI Q, LI D, et al. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease[J]. Atherosclerosis,2020, 299: 45-52. [9] GAO M, CHENG Y, ZHENG Y, et al. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. BMC Cardiovasc Disord, 2017, 17(1): 43. [10] 张琦, 张荣成, 姚佑楠, 等. 肝脏纤维化程度评分在住院心力衰竭患者风险评估中的应用[J]. 中国循环杂志, 2019, 34(8): 796-802. [11] 武金娥, 高凡, 吕军, 等. 急性ST段抬高型心肌梗死患者外周血白细胞、血小板和血红蛋白含量与预后的关系[J]. 中国循证心血管医学杂志, 2020, 12(5): 620-622, 626. [12] CHEN L Z, JING X B, WU C F, et al. Nonalcoholic fatty liver disease-associated liver fibrosis is linked with the severity of coronary artery disease mediated by systemic inflammation[J]. Dis Markers, 2021, 2021: 6591784. [13] SHUMILAHA M, OTHMAN A M, AL-MADHAGI A K. Accuracy of neutrophil to lymphocyte and monocyte to lymphocyte ratios as new inflammatory markers in acute coronary syndrome[J]. BMC Cardiovasc Disord, 2021, 21(1): 422. [14] GUNES H, SARITAS A, CANGUR S, et al. Complete blood count parameters for prediction of non-ST segment elevation myocardial infarction[J]. J Coll Physicians Surg Pak, 2019, 29(8): 710-714. [15] GAGGINI M, MINICHILLI F, GORINI F, et al. FIB-4 index and neutrophil-to-lymphocyte-ratio as death predictor in coronary artery disease patients[J]. Biomedicines, 2022, 11(1): 76. |